BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30935778)

  • 21. The vitamin D
    Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
    J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis.
    Takahashi T; Koga Y; Kainoh M
    Eur J Pharmacol; 2018 Jun; 828():26-30. PubMed ID: 29544684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
    Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
    J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
    Zhou Y; Follansbee T; Wu X; Han D; Yu S; Domocos DT; Shi Z; Carstens M; Carstens E; Hwang ST
    J Dermatol Sci; 2018 Dec; 92(3):264-271. PubMed ID: 30527377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndecan-1 Regulates Psoriasiform Dermatitis by Controlling Homeostasis of IL-17-Producing γδ T Cells.
    Jaiswal AK; Sadasivam M; Archer NK; Miller RJ; Dillen CA; Ravipati A; Park PW; Chakravarti S; Miller LS; Hamad ARA
    J Immunol; 2018 Sep; 201(6):1651-1661. PubMed ID: 30045969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting Protein Kinase Activity of Pyruvate Kinase M2 by SIRT2 Deacetylase Attenuates Psoriasis.
    Hao L; Park J; Jang HY; Bae EJ; Park BH
    J Invest Dermatol; 2021 Feb; 141(2):355-363.e6. PubMed ID: 32679047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nerve injuries attenuate the persistence of psoriatic lesions.
    Qin B; Sun C; Chen L; Wang S; Yang J; Xie Z; Shen Z
    J Dermatol Sci; 2021 May; 102(2):85-93. PubMed ID: 33676787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
    Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
    Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The G Protein-Coupled Receptor (GPR) 15 Counteracts Antibody-Mediated Skin Inflammation.
    Jegodzinski L; Sezin T; Loser K; Mousavi S; Zillikens D; Sadik CD
    Front Immunol; 2020; 11():1858. PubMed ID: 32922401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways.
    Qu R; Chen X; Hu J; Fu Y; Peng J; Li Y; Chen J; Li P; Liu L; Cao J; Wang W; Qiu C; Guo L; Vasilev K; Chen J; Zhou G; Li W; Zhao Y
    Sci Rep; 2019 Feb; 9(1):1348. PubMed ID: 30718736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentraxin 3 exacerbates psoriasiform dermatitis through regulation of macrophage polarization.
    Liu J; Qiu C; Zhou Z; Li J; Zhen Y; Wang R; Zhuang Y; Zhang F
    Int Immunopharmacol; 2024 Mar; 130():111805. PubMed ID: 38457930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotrienes do not modulate the course of Aldara™-induced psoriasiform dermatitis in mice.
    Sezin T; Zillikens D; Sadik CD
    Acta Derm Venereol; 2015 Mar; 95(3):341-2. PubMed ID: 24979074
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis.
    Mabuchi T; Takekoshi T; Hwang ST
    J Immunol; 2011 Nov; 187(10):5026-31. PubMed ID: 21984702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.
    Onderdijk AJ; Hekking-Weijma IM; Florencia EF; Prens EP
    Methods Mol Biol; 2017; 1559():75-81. PubMed ID: 28063038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis.
    Vasseur P; Pohin M; Jégou JF; Favot L; Venisse N; Mcheik J; Morel F; Lecron JC; Silvain C
    Br J Dermatol; 2018 Jul; 179(1):101-109. PubMed ID: 29150843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.
    Shibata S; Tada Y; Hau CS; Mitsui A; Kamata M; Asano Y; Sugaya M; Kadono T; Masamoto Y; Kurokawa M; Yamauchi T; Kubota N; Kadowaki T; Sato S
    Nat Commun; 2015 Jul; 6():7687. PubMed ID: 26173479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.
    Tortola L; Rosenwald E; Abel B; Blumberg H; Schäfer M; Coyle AJ; Renauld JC; Werner S; Kisielow J; Kopf M
    J Clin Invest; 2012 Nov; 122(11):3965-76. PubMed ID: 23064362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRPA1 Acts in a Protective Manner in Imiquimod-Induced Psoriasiform Dermatitis in Mice.
    Kemény Á; Kodji X; Horváth S; Komlódi R; Szőke É; Sándor Z; Perkecz A; Gyömörei C; Sétáló G; Kelemen B; Bíró T; Tóth BI; Brain SD; Pintér E; Gyulai R
    J Invest Dermatol; 2018 Aug; 138(8):1774-1784. PubMed ID: 29550417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aryl Hydrocarbon Receptor in Cutaneous Vascular Endothelial Cells Restricts Psoriasis Development by Negatively Regulating Neutrophil Recruitment.
    Zhu Z; Chen J; Lin Y; Zhang C; Li W; Qiao H; Fu M; Dang E; Wang G
    J Invest Dermatol; 2020 Jun; 140(6):1233-1243.e9. PubMed ID: 31899186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.